Outcome of Patients With Differentiated Thyroid Cancer Treated With 131-Iodine on the Basis of a Detectable Serum Thyroglobulin Level After Initial Treatment-Reference-Cited by-同舟云学术

Outcome of Patients With Differentiated Thyroid Cancer Treated With 131-Iodine on the Basis of a Detectable Serum Thyroglobulin Level After Initial Treatment

Published:2019-03-12 Issue: Volume:10 Page:
ISSN:1664-2392
Container-title:Frontiers in Endocrinology
language:
Short-container-title:Front. Endocrinol.

Author:

Klain Michele,Pace Leonardo,Zampella Emilia,Mannarino Teresa,Limone Simona,Mazziotti Emanuela,De Simini Giovanni,Cuocolo Alberto

Publisher

Frontiers Media SA

Subject

Endocrinology, Diabetes and Metabolism

Reference23 articles.

1. Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer;Ozata;J Clin Endocrinol Metab.,1994

2. Value of stimulated serum thyroglobulin levels for detecting persistent or recurrent differentiated thyroid cancer in high and low-risk patients;Duren;Surgery.,1999

3. Serum and tissue thyroglobulin measurements: clinical applications in thyroid disease;Pacini;Biochimie.,1999

4. A consensus report of the role of serum thyroglobulin as a monitoring method for low risk patients with papillary thyroid carcinoma;Mazzaferri;J Clin Endocrinol Metab.,2003

5. Diagnostic 131-I whole body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment;Pacini;J Clin Endocrinol Metab.,2002

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stimulating thyroglobulin to TSH ratio predict long-term efficacy of 131I therapy in patients with differentiated thyroid cancer after total thyroidectomy: a retrospective study;Endocrine;2024-01-03

2. Alpha emitter isotopes and PSMA ligands: the near future therapeutic prospective for castration-resistant prostate cancer;European Journal of Nuclear Medicine and Molecular Imaging;2023-12-23

3. New opportunities for dosimetric approach in patients with differentiated thyroid cancer;European Journal of Nuclear Medicine and Molecular Imaging;2023-10-23

4. PET/CT imaging with radiolabeled FAPI: new opportunities for diagnosis and treatment of thyroid cancer;European Journal of Nuclear Medicine and Molecular Imaging;2023-09-27

5. Efficacy of Empirical Radioiodine Therapy in Patients with Differentiated Thyroid Cancer and Elevated Serum Thyroglobulin without Evidence of Structural Disease: A Propensity Score Analysis;Cancers;2023-08-21